Recognizing how Optimised Immunopeptidomics & Bioinformatics Methods Lead to Greater Clinical Benefits

Time: 11:30 am
day: Conference Day Two


  • Examining optimised immunopeptidomics assay for productively building up high quality training data
  • An Exclusive look at protein structure based all-in-one analysis pipeline for neoantigen vaccine design and ranking
  • Showcasing clinical data highlighting the efficacy of combination therapies with neoantigen vaccines, and the long-term effective disease control for late-stage patients.